跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
levodopa prodrug
首页
药物
levodopa prodrug
levodopa prodrug
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Levodopa prodrug mesylate, compositions thereof, and uses thereof
US 7563821 B2
申请人: XENOPORT INC
优先权: 2006
US
8 件公开
Methods of synthesizing a levodopa ester prodrug
US 9290445 B2
申请人: RAILLARD STEPHEN P
优先权: 2009
CN
US
4 件公开
Levodopa prodrug mesylate hydrate
US 8399513 B2
申请人: KARABORNI SAMI
优先权: 2009
US
4 件公开
Therapeutic drug for dyskinesia
US 10758535 B1
申请人: SUMITOMO DAINIPPON PHARMA CO LTD
优先权: 2019
CN
EP
US
3 件公开
US 11559525 B2
申请人: SUMITOMO PHARMA CO LTD
优先权: 2021
US
Compound and medical use thereof
US 8748485 B2
申请人: KOKUBO MASAYA
优先权: 2010
US
3 件公开
SUBCUTANEOUSLY INFUSIBLE LEVODOPA PRODRUG COMPOSITIONS AND METHODS OF INFUSION
US 2014088192 A1
申请人: HELLER EPHRAIM
优先权: 2011
CN
US
2 件公开
METHODS AND COMPOSITIONS FOR TREATING PARKINSON’S DISEASE
US 20250082595 A1
申请人: NEURODERM LTD
优先权: 2022
CN
US
2 件公开
Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use
US 8435562 B2
申请人: MAO CHEN
优先权: 2010
US
2 件公开
Stabilized liquid compositions comprising levodopa-tyrosine conjugates and uses thereof
CN 116964069 A
申请人: NEURODERM LTD
优先权: 2022
CN
NOVEL KIT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES
US 20250170076 A1
申请人: BERLIREM GMBH
优先权: 2022
US
第 1 / 2 页
上一页
下一页
药物
反馈